Which chemotherapy agent is used for treatment of transmissible venereal tumor (TVT)?

Prepare for the PAVE Test with our comprehensive study materials. Utilize flashcards, multiple-choice questions, and detailed explanations to boost your understanding. Get ready to excel in your veterinary education evaluation!

Multiple Choice

Which chemotherapy agent is used for treatment of transmissible venereal tumor (TVT)?

Explanation:
Transmissible venereal tumor is a contagious canine cancer that often responds very well to chemotherapy. The preferred treatment is vincristine, a vinca alkaloid that blocks microtubule formation by binding tubulin, which stops cell division during mitosis. This mechanism leads to rapid tumor shrinkage and a high likelihood of complete remission when given as a short course of weekly IV doses. Vincristine typically has a favorable safety profile, allowing outpatient treatment. Other chemotherapeutic drugs like doxorubicin, cyclophosphamide, or methotrexate can be used in different cancers, but they don’t offer the same combination of high efficacy and tolerability for TVT as vincristine.

Transmissible venereal tumor is a contagious canine cancer that often responds very well to chemotherapy. The preferred treatment is vincristine, a vinca alkaloid that blocks microtubule formation by binding tubulin, which stops cell division during mitosis. This mechanism leads to rapid tumor shrinkage and a high likelihood of complete remission when given as a short course of weekly IV doses. Vincristine typically has a favorable safety profile, allowing outpatient treatment. Other chemotherapeutic drugs like doxorubicin, cyclophosphamide, or methotrexate can be used in different cancers, but they don’t offer the same combination of high efficacy and tolerability for TVT as vincristine.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy